Premium
The release of β‐ thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery
Author(s) -
CELLA GIUSEPPE,
VITTADELLO ORNELLA,
GALLUCCI VINCENZO,
GIROLAMI ANTONIO
Publication year - 1981
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/j.1365-2362.1981.tb01836.x
Subject(s) - extracorporeal circulation , cardiopulmonary bypass , platelet factor 4 , platelet , heparin , extracorporeal , medicine , platelet activation , anesthesia , chemistry , surgery
Abstract . Cardiopulmonary bypass is extremely damaging to platelets and it causes a quantitative and qualitative alteration in their functions. We evaluated the release of two platelet‐specific proteins, β‐thromboglobulin (βTG) and platelet factor 4 (PF4), in patients who underwent extracorporeal circulation for open heart surgery. A parallel release (basal value βTG: 119.6 ng/ml, PF4 30 ng/ml) was present for both proteins in a time dependent fashion until the end of extracorporeal circulation. High average levels were observed in patients in whom the bypass was stopped after about 1 h (βTG 1606 ng/ml, PF4 745 ng/ml) and similarly in those in whom the bypass was stopped after about 2 h (βTG 1540 ng/ml, PF 4754 ng/ml). No correlation was found either between the level of PF4 and the additional heparin administered after the initial standard dose ( r = 0.29, P >0.10) and between the level of PF4 and the amount of heparin consumed during the bypass ( r = 0.05, P >0.5).